Skip to main content

Table 5 Prevalence ratio of NCD outcomes with AAM (in years) among female respondents from IFLS wave 4 and 5 (N = 13,267)

From: Trend in age at menarche and its association with body weight, body mass index and non-communicable disease prevalence in Indonesia: evidence from the Indonesian Family Life Survey (IFLS)

Diseases Outcome

Frequencya

Crude model

Age-Adjusted

Age and BMI-adjusted

n (%)

PR

95% CI

PR

95% CI

PR

95% CI

Hypertension

1950 (14.7)

1.03

1.01

1.06

0.98

0.96

1.01

0.99

0.97

1.01

Diabetes Mellitus

283 (2.2)

1.04

0.97

1.12

0.97

0.91

1.03

0.97

0.91

1.03

Asthma

399 (3.0)

1.02

0.96

1.08

1.03

0.97

1.1

1.03

0.97

1.1

Chronic lung diseases

197 (1.5)

0.98

0.90

1.06

0.97

0.90

1.05

0.95

0.88

1.03

Cardiovascular diseases

242 (1.8)

1.09

1.02

1.16

1.03

0.97

1.1

1.03

0.97

1.1

Liver diseases

99 (0.8)

1.08

0.97

1.2

1.08

0.99

1.22

1.09

1.001

1.23

Stroke

71 (0.6)

1.01

0.88

1.15

0.94

0.83

1.06

0.94

0.83

1.06

Cancer

134 (1.0)

0.97

0.89

1.05

0.96

0.88

1.04

0.96

0.89

1.04

Arthritis

826 (6.3)

1.1

1.06

1.14

1.02

0.99

1.06

1.02

0.99

1.06

  1. Note: PR prevalence ratio. Independent variable, AAM dependent variable: NCD
  2. apercentage was measured from total respondents